RNA Therapy for Atherosclerosis: New Approach Beyond Statins @UniversityHospitals

Uploaded April 2026 | Updated September 2026, 1 week ago

Christopher Holley, PhD, Duke University, 2024 Harrington Scholar-Innovator, is developing RNA-targeted therapies to treat atherosclerosis, aiming to reduce cardiovascular disease risk through a novel approach that goes beyond cholesterol management.

Harrington Discovery Institute at University Hospitals in Cleveland, Ohio aims to accelerate promising discoveries into medicines for unmet needs. Learn more: HarringtonDiscovery.org.

RNA Therapy for Atherosclerosis: New Approach Beyond Statins

University Hospitals Global Health Grand Rounds with Matthew Bonds

Ariel Sindel, DO - Hematology & Oncology

University Hospitals Rainbow Babies & Children Advances Sickle Cell Disease Therapy

Kristen’s Comeback: From Multiple ACL Injuries to MVP

Benefits of HAI Therapy – UH Seidman Cancer Center

University Hospitals Health Services Research Center Drives Community Impact and Research Education

Gene Therapy for SPLIS: Advancing a Cure for Rare Kidney Disease

University Hospitals Global Health Grand Rounds with Christine Ngaruiya, MD

Prashant Rajan, MD - Orthopedic Spine Surgery

UH Health Talk: Lifestyle & Integrative Medicine for Female Fertility